Table 4.
Control (n = 39) | POAG (n = 32) | PACG (n = 30) | p* | p** | p*** | |
---|---|---|---|---|---|---|
Central VD (%) | 14.31 ± 5.40 | 14.16 ± 4.18 | 12.70 ± 5.00 | 0.990 | 0.413 | 0.435 |
Quadrant parafoveal VD (%) | ||||||
Superior | 47.23 ± 4.25 | 41.88 ± 6.28 | 43.07 ± 5.28 | 0.000 | 0.002 | 0.698 |
Nasal | 46.05 ± 5.14 | 41.03 ± 5.41 | 42.00 ± 4.43 | 0.001 | 0.002 | 0.721 |
Inferior | 47.92 ± 4.18 | 40.25 ± 6.70 | 43.63 ± 4.80 | 0.000 | 0.001 | 0.065 |
Temporal | 46.13 ± 3.55 | 39.06 ± 5.57 | 42.00 ± 4.76 | 0.000 | 0.001 | 0.073 |
Values are presented as mean ± standard deviation unless otherwise indicated. *Comparison between the control and POAG groups (Games-Howell post-hoc test). **Comparison between the control and PACG groups (Games-Howell post-hoc test). ***Comparison between the POAG and PACG groups (Games-Howell post-hoc test). VD, vessel density; PACG, primary angle-closure glaucoma; POAG, primary open-angle glaucoma.